As Testosterone Treatment Lawsuits Mount, Bernstein Liebhard LLP Notes Scheduling of FDA Meeting to
The Firm is evaluating testosterone lawsuits on behalf of men who allegedly suffered heart attacks, strokes, and other cardiovascular problems due to their use of testosterone replacement medications. New York, NY (PRWEB) July 21, 2014 As testosterone treatment lawsuits (http://www.testosteronelawsuitclaims.com/) continue to mount in U.S. courts, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) has scheduled a meeting of outside advisors to discuss the risks associated with prescription low testosterone therapy. According to a notice posted on the agency’s we
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 313
- Bankruptcy 44
- Business 135
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 58
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4